Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data

por Khan, Mohammed Ayaz, Sherbini, Nahed, Alyami, Sami, Al-Harbi, Abdullah, Al-Ghamdi, Majed, Alrajhi, Suliman, Rajendram, Rajkumar, Al-Jahdali, Hamdan
Publicado 2023

A survival analysis of idiopathic pulmonary fibrosis in the context of antifibrotic therapy in Saudi Arabia

por Khan, Mohammed Ayaz, Ghamdi, Basma Al, Alhamadi, Mohammed, Rajendram, Rajkumar, Alyami, Sami, Al-Gamedi, Majed, Al-Harbi, Abdullah, Al-Jahdali, Hamdan
Publicado 2023